Covered recipient · General Payments record
ANTHONY BONFIGLIO
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$4,097.67
- Reported across 232 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $436.17 | 33 |
| Education | $8.45 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $174.84 | 18 |
| Lilly USA, LLC | $145.36 | 10 |
| E.R. Squibb & Sons, L.L.C. | $27.43 | 1 |
| UCB, Inc. | $23.39 | 1 |
| Galderma Laboratories, L.P. | $20.57 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $18.86 | 1 |
| Paratek Pharmaceuticals, Inc. | $18.40 | 1 |
| Janssen Biotech, Inc. | $15.77 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $2.28 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103346192 | CMS |
| ABBVIE INC. | $8.45 | 03/04/2024 | Education | Undisputed | 01/23/2026 | 1104194482 | CMS |
| ABBVIE INC. | $7.89 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103346194 | CMS |
| ABBVIE INC. | $12.35 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103346196 | CMS |
| ABBVIE INC. | $7.89 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103346198 | CMS |
| ABBVIE INC. | $13.70 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103346200 | CMS |
| ABBVIE INC. | $7.22 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103346202 | CMS |
| ABBVIE INC. | $7.47 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103346204 | CMS |
| ABBVIE INC. | $8.08 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103346206 | CMS |
| ABBVIE INC. | $8.32 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103346208 | CMS |
| ABBVIE INC. | $8.51 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103346210 | CMS |
| ABBVIE INC. | $14.74 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103346212 | CMS |
| ABBVIE INC. | $12.67 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103346214 | CMS |
| ABBVIE INC. | $9.31 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103346216 | CMS |
| ABBVIE INC. | $13.34 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103346218 | CMS |
| ABBVIE INC. | $10.21 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103346220 | CMS |
| ABBVIE INC. | $14.67 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103346222 | CMS |
| ABBVIE INC. | $7.74 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103346224 | CMS |
| E.R. Squibb & Sons, L.L.C. | $27.43 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101266151 | CMS |
| Galderma Laboratories, L.P. | $20.57 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145287189 | CMS |
| Janssen Biotech, Inc. | $15.77 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078838222 | CMS |
| Lilly USA, LLC | $22.97 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136046221 | CMS |
| Lilly USA, LLC | $12.55 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135999859 | CMS |
| Lilly USA, LLC | $1.28 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135999861 | CMS |
| Lilly USA, LLC | $20.75 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136042912 | CMS |
| Lilly USA, LLC | $17.09 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136042914 | CMS |
| Lilly USA, LLC | $17.87 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136058706 | CMS |
| Lilly USA, LLC | $8.42 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136050953 | CMS |
| Lilly USA, LLC | $17.77 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136050955 | CMS |
| Lilly USA, LLC | $14.01 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136058704 | CMS |
| Lilly USA, LLC | $12.65 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136050957 | CMS |
| Paratek Pharmaceuticals, Inc. | $18.40 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113893400 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $18.86 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152126509 | CMS |
| UCB, Inc. | $23.39 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143157566 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.